|
[size=18.000000pt]Health-related quality of life and neurocognitive functioningwith lomustine–temozolomide versus temozolomide inpatients with newly diagnosed, [size=18.000000pt]MGMT-[size=18.000000pt]methylatedglioblastoma (CeTeG/NOA-09): a randomised, multicentre,open-label, phase 3 trial
|
本帖子中包含更多资源
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
|